BIOAFFINITY TECHNOLOGIES ($BIAF) is expected to release its quarterly earnings data on Friday, March 28th after market close, per Finnhub. Analysts are expecting revenue of $2,466,360 and earnings of -$0.14 per share.
You can see Quiver Quantitative's $BIAF stock page to track data on insider trading, hedge fund activity, congressional trading, and more.
BIOAFFINITY TECHNOLOGIES Hedge Fund Activity
We have seen 7 institutional investors add shares of BIOAFFINITY TECHNOLOGIES stock to their portfolio, and 8 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- SHEAFF BROCK INVESTMENT ADVISORS, LLC added 26,304 shares (+131.5%) to their portfolio in Q4 2024, for an estimated $23,936
- RENAISSANCE TECHNOLOGIES LLC removed 22,967 shares (-100.0%) from their portfolio in Q3 2024, for an estimated $47,771
- GROUND SWELL CAPITAL, LLC removed 22,864 shares (-100.0%) from their portfolio in Q3 2024, for an estimated $47,557
- TWO SIGMA SECURITIES, LLC added 14,420 shares (+inf%) to their portfolio in Q4 2024, for an estimated $13,122
- CITADEL ADVISORS LLC added 13,264 shares (+inf%) to their portfolio in Q4 2024, for an estimated $12,070
- GEODE CAPITAL MANAGEMENT, LLC added 12,370 shares (+14.2%) to their portfolio in Q4 2024, for an estimated $11,256
- UBS GROUP AG removed 9,591 shares (-100.0%) from their portfolio in Q3 2024, for an estimated $19,949
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
